Inhibitory KIR-Ligand Interactions and Relapse Protection Following HLA Matched Allogeneic HCT for AML
Publication/Presentation Date
2020
Published In/Presented At
Krieger, E., Qayyum, R., & Toor, A. Inhibitory Killer Immunoglobulin-like Receptor-Ligand Interactions and NK Cell Alloreactivity Potential Following HLA Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia. MedRxiv 2020.07.10.20149047
Department(s)
Department of Medicine, Hematology-Medical Oncology Division
Document Type
Article
COinS